Mitoxantrone

Mitoxantrone is a dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone that is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8. Among its listed roles, it functions as a antineoplastic agent and an analgesic. An anthracenedione-derived antineoplastic agent. Mitoxantrone is a Topoisomerase Inhibitor. The mechanism of action of mitoxantrone is as a Topoisomerase Inhibitor. It is grouped under the following drug class(es): Anthracyclines, Cytotoxics and Topoisomerase inhibitors. Its therapeutic use is listed as anti-cancer agents and multiple sclerosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Misostol, Mitozantrone and Novantrone. Its PubChem CID is 4212.

CAS No 65271-80-9
Molecular Formula C22H28N4O6
Molecular Weight 444.50 g/mol
Synonyms 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione

Frequently Asked Questions